Dr. Soliman Abdel Kader Fakeeh Hospital Company's (TADAWUL:4017) largest shareholder, CEO Mazen Soliman Abdel Fakeeh sees holdings value fall by 4.0% following recent drop

Key Insights

• Insiders appear to have a vested interest in Dr. Soliman Abdel Kader Fakeeh Hospital's growth, as seen by their sizeable ownership
• The top 2 shareholders own 62% of the company
• Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Every investor in Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual insiders with 78% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

And following last week's 4.0% decline in share price, insiders suffered the most losses.

In the chart below, we zoom in on the different ownership groups of Dr. Soliman Abdel Kader Fakeeh Hospital.

View our latest analysis for Dr. Soliman Abdel Kader Fakeeh Hospital

What Does The Institutional Ownership Tell Us About Dr. Soliman Abdel Kader Fakeeh Hospital?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Institutions have a very small stake in Dr. Soliman Abdel Kader Fakeeh Hospital. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. If the business gets stronger from here, we could see a situation where more institutions are keen to buy. When multiple institutional investors want to buy shares, we often see a rising share price. The past revenue trajectory (shown below) can be an indication of future growth, but there are no guarantees.

Dr. Soliman Abdel Kader Fakeeh Hospital is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is the CEO Mazen Soliman Abdel Fakeeh with 31% of shares outstanding. In comparison, the second and third largest shareholders hold about 31% and 16% of the stock. Interestingly, the third-largest shareholder, Manal Soliman Abdel Fakeeh is also a Vice Chairman, again, indicating strong insider ownership amongst the company's top shareholders.

After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Dr. Soliman Abdel Kader Fakeeh Hospital

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

It seems that insiders own more than half the Dr. Soliman Abdel Kader Fakeeh Hospital Company stock. This gives them a lot of power. Insiders own ر.س6.0b worth of shares in the ر.س7.8b company. That's extraordinary! Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if they have been selling down their stake.

General Public Ownership

With a 21% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Dr. Soliman Abdel Kader Fakeeh Hospital. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Dr. Soliman Abdel Kader Fakeeh Hospital better, we need to consider many other factors.

I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.